Trial Profile
Pharmacokinetic Study Comparing Two Budesonide/Formoterol Fumarate Dihydrate Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler 320/9 Microg/Inhalation and Symbicort Turbuhaler Forte; a Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2012
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2012 New trial record